Annual CFF
$14.03 M
-$1.17 M-7.72%
01 December 2023
Summary:
Revelation Biosciences annual cash flow from financing activities is currently $14.03 million, with the most recent change of -$1.17 million (-7.72%) on 01 December 2023. REVB annual CFF is now -95.85% below its all-time high of $338.19 million, reached on 01 December 2019.REVB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$3.74 M
+$3.74 M+100.00%
01 September 2024
Summary:
Revelation Biosciences quarterly cash flow from financing activities is currently $3.74 million, with the most recent change of +$3.74 million (+100.00%) on 01 September 2024. Over the past year, it has increased by +$3.74 million (+100.00%). REVB quarterly CFF is now -73.31% below its all-time high of $14.03 million, reached on 31 March 2023.REVB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$9.16 M
+$3.74 M+69.09%
01 September 2024
Summary:
Revelation Biosciences TTM cash flow from financing activities is currently $9.16 million, with the most recent change of +$3.74 million (+69.09%) on 01 September 2024. Over the past year, it has dropped by -$4.87 million (-34.69%). REVB TTM CFF is now -50.44% below its all-time high of $18.48 million, reached on 31 March 2023.REVB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | -34.7% |
| 3 y3 years | - | +100.0% | +14.4% |
| 5 y5 years | -95.8% | - | - |
REVB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.7% | +75.2% | -73.3% | -50.4% | +69.1% | |
| 5 y | 5 years | -95.8% | +75.2% | -73.3% | -50.4% | +69.1% | |
| alltime | all time | -95.8% | +75.2% | -73.3% | -50.4% | +69.1% |
Revelation Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.74 M(>+9900.0%) | $9.16 M(+69.1%) |
| June 2024 | - | $0.00(-100.0%) | $5.42 M(0.0%) |
| Mar 2024 | - | $5.42 M(>+9900.0%) | $5.42 M(-61.4%) |
| Dec 2023 | $14.03 M(-7.7%) | $0.00(0.0%) | $14.03 M(-0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $14.03 M(-24.1%) |
| June 2023 | - | $0.00(-100.0%) | $18.48 M(0.0%) |
| Mar 2023 | - | $14.03 M(>+9900.0%) | $18.48 M(+21.6%) |
| Dec 2022 | $15.20 M | $5000.00(-99.9%) | $15.20 M(+0.0%) |
| Sept 2022 | - | $4.45 M(>+9900.0%) | $15.19 M(+41.4%) |
| June 2022 | - | $0.00(-100.0%) | $10.74 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $10.74 M(>+9900.0%) | $10.74 M(+34.2%) |
| Dec 2021 | $8.00 M(-97.6%) | $0.00(0.0%) | $8.00 M(0.0%) |
| Sept 2021 | - | $0.00(0.0%) | $8.00 M(0.0%) |
| June 2021 | - | $0.00(-100.0%) | $8.00 M(0.0%) |
| Mar 2021 | - | $8.00 M | $8.00 M |
| Dec 2019 | $338.19 M(+3.1%) | - | - |
| Dec 2018 | $327.97 M(+75.7%) | - | - |
| Dec 2017 | $186.71 M(-30.9%) | - | - |
| Dec 2016 | $270.02 M(+36.6%) | - | - |
| Dec 2015 | $197.74 M | - | - |
FAQ
- What is Revelation Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Revelation Biosciences?
- What is Revelation Biosciences quarterly CFF year-on-year change?
- What is Revelation Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Revelation Biosciences?
- What is Revelation Biosciences TTM CFF year-on-year change?
What is Revelation Biosciences annual cash flow from financing activities?
The current annual CFF of REVB is $14.03 M
What is the all time high annual CFF for Revelation Biosciences?
Revelation Biosciences all-time high annual cash flow from financing activities is $338.19 M
What is Revelation Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of REVB is $3.74 M
What is the all time high quarterly CFF for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash flow from financing activities is $14.03 M
What is Revelation Biosciences quarterly CFF year-on-year change?
Over the past year, REVB quarterly cash flow from financing activities has changed by +$3.74 M (+100.00%)
What is Revelation Biosciences TTM cash flow from financing activities?
The current TTM CFF of REVB is $9.16 M
What is the all time high TTM CFF for Revelation Biosciences?
Revelation Biosciences all-time high TTM cash flow from financing activities is $18.48 M
What is Revelation Biosciences TTM CFF year-on-year change?
Over the past year, REVB TTM cash flow from financing activities has changed by -$4.87 M (-34.69%)